James Shin
Stock Analyst at Deutsche Bank
(2.75)
# 2,034
Out of 5,090 analysts
23
Total ratings
60%
Success rate
21.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $99.72 | +11.31% | 3 | Nov 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,010 → $900 | $1,010.31 | -10.92% | 5 | Aug 11, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $10.18 | -1.77% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $121.22 | -1.01% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $329.89 | -7.54% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $102.52 | -41.47% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $52.15 | -13.71% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $28.13 | +113.30% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $226.08 | -33.65% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $718.36 | +11.36% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.55 | +545.16% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $8.66 | +1,285.68% | 1 | Nov 9, 2023 |
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $99.72
Upside: +11.31%
Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010 → $900
Current: $1,010.31
Upside: -10.92%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $10.18
Upside: -1.77%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $121.22
Upside: -1.01%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $329.89
Upside: -7.54%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $102.52
Upside: -41.47%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $52.15
Upside: -13.71%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $28.13
Upside: +113.30%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $226.08
Upside: -33.65%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $718.36
Upside: +11.36%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.55
Upside: +545.16%
Nov 9, 2023
Initiates: Buy
Price Target: $120
Current: $8.66
Upside: +1,285.68%